| FFAI 0.5319 85.52% | BYND 1.045 -9.91% | CTNT 0.0445 -18.80% | FCHL 0.2835 26.00% | TZA 5.14 2.90% | LOBO 0.6848 19.59% | ASBP 0.1968 -24.86% | BURU 0.2602 30.10% | RPGL 0.7163 59.21% | BITO 10.29 -1.63% | NVDA 199.88 -1.08% | SOXS 18.2 -2.31% | INTC 66.26 0.85% | TQQQ 57.4 -1.17% | NVTS 15.33 16.14% | BMNG 1.43 -7.74% | PLUG 3.08 -4.35% | LOCL 3.03 61.17% | ONDS 10.87 1.30% | SPDN 9.2 0.66% | OPEN 5.45 1.87% | XRTX 2.69 19.56% | TSLL 12.87 -3.16% | EDBL 0.6896 -25.04% | SQQQ 57.59 1.19% | NVD 5.71 2.15% | AAL 11.77 -3.84% | SOFI 18.83 -3.44% | SOXL 98.09 2.24% | NOK 10.3968 -1.92% | BTG 4.72 -4.45% | HIMS 29.76 -4.03% | SPY 704.08 -0.65% | HYG 80.37 -0.26% | POET 10.25 19.32% | SNAP 5.65 -5.83% | SOUN 7.85 -5.65% | NFLX 92.58 -2.37% | TOVX 0.3387 -17.39% | SCO 7.59 -5.52% | TSLA 386.42 -1.55% | SLNH 1.31 -6.43% | AAPL 266.17 -2.52% | SOWG 0.1672 -30.30% | LCID 7.11 5.33% | SMR 11.67 -8.76% | GRAB 4.08 -3.09% | PLTR 145.97 0.05% | AMZN 249.91 0.66% | SIDU 3.75 -13.59%

HealthEquity, Inc. (NASDAQ: HQY) Maintains Strong Financial Performance

HealthEquity, Inc. (NASDAQ: HQY) is a prominent player in the medical services industry, specializing in health savings accounts (HSAs) and related financial services. The company is known for its strong financial performance and strategic initiatives aimed at enhancing member savings, spending, and investment strategies. HealthEquity competes with other financial service providers in the healthcare sector, striving to maintain its market position through consistent growth and innovation.

On December 4, 2025, Citigroup maintained its "Outperform" rating for HQY, with the stock priced at $98.64. This rating reflects confidence in HealthEquity's ability to deliver strong financial results and maintain its competitive edge. Citizens JMP also raised the price target for HQY from $117 to $122, as highlighted by TheFly, indicating positive expectations for the company's future performance.

HealthEquity's recent Q3 2026 earnings call, as reported by Seeking Alpha, showcased the company's impressive financial results. The company reported earnings of $1.01 per share, surpassing the Zacks Consensus Estimate of $0.90 per share. This represents a 12.22% earnings surprise and a significant increase from the $0.78 per share reported in the same quarter last year. HealthEquity has consistently exceeded consensus EPS estimates in three of the past four quarters.

In terms of revenue, HealthEquity generated $322.16 million for the quarter ending October 2025, exceeding the Zacks Consensus Estimate by 0.69%. This marks a 7% increase from the $300.43 million reported in the same period last year. The company's strong revenue growth is a testament to its ability to capitalize on market opportunities and deliver value to its stakeholders.

HealthEquity's strategic initiatives have also contributed to its financial success. The company returned $93.7 million to shareholders through stock repurchases and implemented a $2.25 billion 5-year Treasury bond hedge to mitigate HSA cash repricing risk. With total HSA assets growing by 15% to $34.4 billion, HealthEquity continues to demonstrate its commitment to enhancing member savings and investment strategies.

Published on: December 4, 2025